Beyond the SSRIs.
- Author:
Min Soo LEE
;
Jong Won NAM
- Publication Type:Original Article
- Keywords:
Depression;
Newer antidepressants;
SSRIs
- MeSH:
Antidepressive Agents;
Antidepressive Agents, Tricyclic;
Depression;
Lithium;
Monoamine Oxidase Inhibitors;
Venlafaxine Hydrochloride
- From:Journal of the Korean Society of Biological Psychiatry
1999;6(1):34-40
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
New antidepressants have become available for clinical use in the 1990s. Before this decade, the drugs available to treat depression consisted essentially of monoamine oxidase inhibitors, tricyclic antidepressants, and lithium. Following the introduction of SSRIs, the options have expanded and now include SSRIs nefazodone, venlafaxine, mirtazapine, reboxetine, tianeptine. Newer antidepressants possess a variety of pharmacological characteristics that are relevant to the choice of an antidepressant for clinical use. This review summarizes some of the major pharmacological characteristics among the drugs.
